ArticleClinical ophthalmology (Auckland, N.Z.)2025
Enhancing Phacoemulsification Safety: How Low Fluidic Settings Influence Active Surge Mitigation Actuation.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Occlusion Break Surge and Anterior Chamber Stability in the Intraocular Environment of Modern Phacoemulsification: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Active Surge Mitigation (ASM) is a feature of the Centurion Vision System ACTIVE SENTRY Methods: This retrospective study was conducted at the University Eye Clinic, University Hospital "Sveti Duh" in Zagreb, Croatia, between January 19 and April 12, 2024. Preoperative parameters included age, gender, biometric data from the Zeiss IOL Master 700, and lens hardness, classified according to the Lens Opacities Classification System (LOCS III). The presence of Pseudoexfoliation Syndrome (PEX) and Intraoperative Floppy Iris Syndrome (IFIS) was noted. Intraoperative metrics recorded were total case time, cumulative dissipated energy (CDE), ultrasound time (U/S time), and the number of ASM actuations. Results: ASM actuations were not normally distributed (median = 1; mean = 2.4). Significant positive correlations were identified with age (P = 0.014), lens thickness (P = 0.039), and U/S time (P = 0.015), while no significant differences were observed for anterior chamber depth (ACD), gender, PEX, or IFIS. Logistic regression identified age as a predictor of ASM values ≥1. Conclusion: At low IOP settings, surge events during phacoemulsification are rare. ASM activation is influenced by patient age, lens thickness, and U/S time but not by ACD, gender, PEX, or IFIS. Low IOP fluidics combined with ASM contributes to stable and safe chamber dynamics across diverse patient profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.